Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06329375 · ClinicalTrials.gov registry record · NA

Food Insecurity Reduction & Strategy Team

A NA study of Diabetes Mellitus, Type 2 and Diabetes Mellitus, Type 1, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
160
Enrollment target
1
Study location

NCT06329375: Recruiting NA study of Diabetes Mellitus, Type 2 and Diabetes Mellitus, Type 1, sponsored by Stanford University.

NCT06329375 is a NA study of Diabetes Mellitus, Type 2 and Diabetes Mellitus, Type 1 that is actively recruiting participants, run by Stanford University. The registered enrollment target is 160 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06329375, a NA study of Diabetes Mellitus, Type 2 and Diabetes Mellitus, Type 1, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

This study seeks to address the multifaceted challenges posed by food disparities and their negative consequences on health outcomes, via a comprehensive community health intervention program. Study objectives include: 1. To describe the social-demographic and clinical factors associated with food insecurity in the hospitalized diabetic population. 2. To design, implement and evaluate a nutrition program targeting the hospitalized diabetic population. The investigators will prospectively randomize the target population into either a nutrition program (Intervention), or state-of-art standard of care (SOC) in a 4:1 ratio. Participants in the intervention group will be provided the following two resources in addition to SOC: 1) Enhanced access to nutritious food (twice daily meal delivery up to 90 days post-discharge) 2) Education at discharge and continuing outreach to enhance knowledge for better diet and food options. 3. To enhance community engagement and develop a systematic implementation plan for long-term roll-out of the nutrition program.

Primary Outcome

Primary outcome is whether the participant had food insecurity in the past 30 days, measured at 60-days post initial discharge by the Food Insecurity Reduction and Strategy Team (FIRST) Survey Instrument questionnaire. 1. Within the past 30 days, you were worried that your food would run out before you got the money to buy more. (Categorical) a. Never true, Sometimes true, Often true, Patient refused 2. Within the past 30 days, the food you bought just didn't last and you didn't have money

Interventions

  • OTHER Nutrition program

Study Locations (1)

California

  • Stanford Medicine - Palo Alto

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2024-10-07
Est. Completion 2026-08-31
Phase NA
Stanford University

1,744 total trials

What NCT06329375 shows while recruiting

NCT06329375 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (96% lower).

The record links to 3 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Nutrition program is the first listed.

NCT06329375 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06329375 about?

NCT06329375 is a clinical study titled "Food Insecurity Reduction & Strategy Team". This study seeks to address the multifaceted challenges posed by food disparities and their negative consequences on health outcomes, via a comprehensive community health intervention program. Study objectives include: 1. To describe the social-demographic and clinical factors associated with food ...

What is the current status of trial NCT06329375?

This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2024-10-07. Estimated completion is 2026-08-31.

What conditions does trial NCT06329375 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Food Insecurity.

What interventions are being tested in trial NCT06329375?

The interventions under investigation include: Nutrition program (OTHER).

Who is sponsoring clinical trial NCT06329375?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06329375 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06329375's enrollment target sits among peer trials

160 168th of 348 higher than 181 of 348 other Diabetes Mellitus, Type 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00501826 · 160 participants · Phase 2

    Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

  • NCT00932139 · 160 participants · NA

    Effect of Electro-Acupuncture on Blood Pressure

  • NCT00992901 · 160 participants · Early Phase 1

    Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

  • NCT01515527 · 160 participants · Phase 2

    Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06329375, the US trial registry maintained by the National Library of Medicine. NCT06329375 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.